This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Practical Applications of Recent Antipsychotic Effectiveness Data.

Jeffrey A. Lieberman, M.D.; Phillip D. Harvey, Ph.D.; John W. Newcomer, M.D.; and Robert A. Rosenheck, M.D.

Published: January 15, 2007

Article Abstract

Click to enlarge page

At its introduction in 1989, clozapine— the first and prototype of the "atypical" or "second-generation" antipsychotics— was thought to be a major advancement in the treatment of severe mental illness. Clozapine and the atypical antipsychotics developed in its wake were thought to be more effective and have fewer side effects than the conventional antipsychotics. Although the atypical antipsychotics had fewer neurologic side effects, they had a greater propensity to cause weight gain and metabolic side effects.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: